Cyclophosphamide (Endoxana)

Cyclophosphamide is an approved anti-cancer drug which is active, alone or in combination, against a wide spectrum of tumours. It is being tested as a treatment for lymphoma.

It comes either as tablets or as a liquid for intravenous injection. Its most significant side-effects are hair loss, nausea and vomiting. Thrombocytopenia and haemorrhagic cystitis have also been observed.

Cyclosphosphamide is manufactured by Pharmacia & Upjohn. Another version, sold under the brandname Endoxana, is made by ASTA Medica.

Up a level
Back to contents
This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.